Viewing Study NCT04340193


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2025-12-25 @ 11:21 PM
Study NCT ID: NCT04340193
Status: COMPLETED
Last Update Posted: 2024-11-26
First Post: 2020-04-07
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancer
Sponsor: Bristol-Myers Squibb
Organization: